Sistemes d'Informació, Institut Català de la Salut, Barcelona, Catalonia, Spain.
Unitat d'informació i Coneixement, Servei Català de la Salut, Barcelona, Spain.
BMC Fam Pract. 2020 Feb 17;21(1):39. doi: 10.1186/s12875-020-01104-1.
Multimorbidity is highly relevant for both service commissioning and clinical decision-making. Optimization of variables assessing multimorbidity in order to enhance chronic care management is an unmet need. To this end, we have explored the contribution of multimorbidity to predict use of healthcare resources at community level by comparing the predictive power of four different multimorbidity measures.
A population health study including all citizens ≥18 years (n = 6,102,595) living in Catalonia (ES) on 31 December 2014 was done using registry data. Primary care service utilization during 2015 was evaluated through four outcome variables: A) Frequent attendants, B) Home care users, C) Social worker users, and, D) Polypharmacy. Prediction of the four outcome variables (A to D) was carried out with and without multimorbidity assessment. We compared the contributions to model fitting of the following multimorbidity measures: i) Charlson index; ii) Number of chronic diseases; iii) Clinical Risk Groups (CRG); and iv) Adjusted Morbidity Groups (GMA).
The discrimination of the models (AUC) increased by including multimorbidity as covariate into the models, namely: A) Frequent attendants (0.771 vs 0.853), B) Home care users (0.862 vs 0.890), C) Social worker users (0.809 vs 0.872), and, D) Polypharmacy (0.835 vs 0.912). GMA showed the highest predictive power for all outcomes except for polypharmacy where it was slightly below than CRG.
We confirmed that multimorbidity assessment enhanced prediction of use of healthcare resources at community level. The Catalan population-based risk assessment tool based on GMA presented the best combination of predictive power and applicability.
多病共存对服务规划和临床决策都非常重要。为了优化评估多病共存的变量,以加强慢性病管理,这是一个未满足的需求。为此,我们通过比较四种不同的多病共存衡量标准对预测社区层面医疗资源使用的能力,探索了多病共存的作用。
使用登记数据开展了一项包括所有 2014 年 12 月 31 日居住在加泰罗尼亚(西班牙)的≥18 岁公民(n=6102595)的人群健康研究。通过四个结果变量评估 2015 年的初级保健服务使用情况:A)频繁就诊者,B)家庭护理使用者,C)社工使用者,和 D)多药使用者。在有无多病共存评估的情况下,对四个结果变量(A 到 D)进行预测。我们比较了以下多病共存衡量标准对模型拟合的贡献:i)Charlson 指数;ii)慢性病数量;iii)临床风险组(CRG);和 iv)调整后的疾病组(GMA)。
将多病共存作为协变量纳入模型后,模型的区分度(AUC)增加,即:A)频繁就诊者(0.771 比 0.853),B)家庭护理使用者(0.862 比 0.890),C)社工使用者(0.809 比 0.872),和 D)多药使用者(0.835 比 0.912)。除了多药使用者外,GMA 在所有结局中的预测能力均最高,而在多药使用者中,CRG 略高于 GMA。
我们证实,多病共存评估提高了对社区层面医疗资源使用的预测能力。基于 GMA 的加泰罗尼亚人群风险评估工具在预测能力和适用性方面具有最佳组合。